Compare AHRT & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AHRT | CLPT |
|---|---|---|
| Founded | 1979 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 539.3M | 467.9M |
| IPO Year | 2013 | 2009 |
| Metric | AHRT | CLPT |
|---|---|---|
| Price | $6.24 | $13.70 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $20.00 |
| AVG Volume (30 Days) | 531.8K | ★ 543.7K |
| Earning Date | 05-04-2026 | 05-13-2026 |
| Dividend Yield | ★ 9.30% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $285,201,000.00 | $36,971,000.00 |
| Revenue This Year | $854.92 | $45.67 |
| Revenue Next Year | $11.36 | $19.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $5.13 | $8.27 |
| 52 Week High | $7.20 | $30.10 |
| Indicator | AHRT | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 35.37 | 42.85 |
| Support Level | $5.93 | $13.42 |
| Resistance Level | $7.19 | $15.29 |
| Average True Range (ATR) | 0.14 | 0.61 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 15.96 | 25.25 |
AH Realty Trust Inc is a real estate investment trust (REIT). It owns, operates, and acquires high-quality properties across the Mid-Atlantic and Southeast, creating lasting value for investors, partners, clients, tenants, and communities. The group focuses on operating and acquiring high-quality, well-positioned assets with growth potential and delivering long-term value for shareholders. Its portfolio includes Harbor Point, Southern Post, The Interlock, and Others.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.